TY - JOUR
T1 - Fragment molecular orbital method
T2 - Application to molecular dynamics simulation, 'ab initio FMO-MD'
AU - Komeiji, Yuto
AU - Nakano, Tatsuya
AU - Fukuzawa, Kaori
AU - Ueno, Yutaka
AU - Inadomi, Yuichi
AU - Nemoto, Tadashi
AU - Uebayasi, Masami
AU - Fedorov, Dmitri G.
AU - Kitaura, Kazuo
N1 - Funding Information:
Y. Komeiji is grateful to Dr. Tohru Terada of RIKEN for advice regarding the temperature constraint method. Development of the A binit-mp program has been supported by a grant-in-aid to T. Nakano from the Information-technology Promotion Agency (IPA). We thank Tsukuba Advanced Computing Center (TACC) for computer support.
PY - 2003/4/29
Y1 - 2003/4/29
N2 - A quantum molecular simulation method applicable to biological molecules is proposed. Ab initio fragment molecular orbital method-based molecular dynamics (FMO-MD) combines molecular dynamics simulation with the ab initio fragment molecular orbital method. Here, FMO computes the force acting on each atom's nucleus while MD computes the nuclei's time-dependent evolutions. FMO-MD successfully simulated a small polypeptide, demonstrating the method's applicability to biological molecules.
AB - A quantum molecular simulation method applicable to biological molecules is proposed. Ab initio fragment molecular orbital method-based molecular dynamics (FMO-MD) combines molecular dynamics simulation with the ab initio fragment molecular orbital method. Here, FMO computes the force acting on each atom's nucleus while MD computes the nuclei's time-dependent evolutions. FMO-MD successfully simulated a small polypeptide, demonstrating the method's applicability to biological molecules.
UR - http://www.scopus.com/inward/record.url?scp=0344950464&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0344950464&partnerID=8YFLogxK
U2 - 10.1016/S0009-2614(03)00430-5
DO - 10.1016/S0009-2614(03)00430-5
M3 - Article
AN - SCOPUS:0344950464
VL - 372
SP - 342
EP - 347
JO - Chemical Physics Letters
JF - Chemical Physics Letters
SN - 0009-2614
IS - 3-4
ER -